Product Description
Overall, the global intravenous (IV) set market was valued at $6.0 billion in 2023, a 5.1% increase from $5.7 billion in 2022. This is expected to increase over the forecast period at a CAGR of 4.1% to reach $7.9 billion. Currently, the global intravenous set market is dominated by Becton Dickinson (BD) and B. Braun.
Throughout this medical market research, we analyzed over 25 intravenous set companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for intravenous sets includes pump sets, secondary sets, gravity sets and extension sets.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
GLOBAL INTRAVENOUS SET MARKET INSIGHTS 
In the dynamic landscape of surgical procedures and trauma cases, there is a significant surge in the need for intravenous (IV) sets. Whether in the bustling environment of hospital operating rooms or in ambulatory settings, IV therapy plays a crucial role as a lifeline for the administration of fluids and precise drug delivery. Furthermore, in emergency situations, critical care scenarios, and trauma cases, the immediate and reliable access to veins becomes absolutely critical for resuscitation and stabilization. It is during these intense and time-sensitive moments that the demand for IV sets escalates dramatically, fueled by the indispensable necessity for consistent vascular access.
GLOBAL INTRAVENOUS SET MARKET SHARE INSIGHTS
In the year 2023, Becton Dickinson (BD) emerged as the top player in the global IV set market. BD’s stronghold in various other infusion therapy and related treatment markets over the years played a pivotal role in its leading position. BD’s unique advantage lies in its capability to bundle IV sets with other products, a strategy that significantly benefits the company. This approach occasionally enables BD to offer IV sets in bulk volumes and at a cost per set that smaller competitors cannot match.
Securing the second spot in the global IV set market in 2023 was B. Braun. The company had a robust presence in the pump set market, driven by its dominant position in the large-volume infusion pump segment. B. Braun held a significant share of the IV set market, particularly in certain key Western European markets like Germany and Italy. Beyond Western Europe, the company also maintained notable, though somewhat smaller, shares.
The remaining portion of the IV set market was fragmented among a diverse array of competitors. The relatively low manufacturing costs for IV sets make it an attractive space for smaller players to enter. Furthermore, most companies engaged in the production and sale of infusion pumps also offer infusion sets to complement their capital products.
MARKET SEGMENTATION SUMMARY
- Pump Set Market – Segmented By:
- Care Setting: Hospital, Non-Hospital
- Gravity Set Market – Segmented By:
- Hospital, Non-Hospital
- Secondary Set Market – Segmented By:
- Care Setting: Hospital, Non-Hospital
- Extension Set Market – Segmented By:
- Care Setting: Hospital
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
